HCPCS drug code · CMS crosswalk
Abecma HCPCS Code
In short
Abecma is billed under HCPCS Q2055. One billing unit is up to 510 million autologous anti-bcma car-positive viable t cells. CMS's crosswalk lists 3 Abecma NDCs under this code.
Reference
- Q2055
- HCPCS Level II drug codeBilling unit: up to 510 million autologous anti-bcma car-positive viable t cells
- Labelers
- Celgene Corporation
Medicare Part B payment limit
CMS ASP fileEffective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. CMS note: Inflation-adjusted coinsurance. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Abecma units and claim line
Enter the dose given to get the Q2055 units and the NDC line for the CMS-1500 and the 837P.
Enter the units to build the claim line.
Abecma NDCs and billing units
From CMS’s ASP NDC–HCPCS crosswalk, effective October 1, 2026 through December 31, 2026. Billing units per package are CMS’s figures for the code’s unit.
| NDC (11-digit) | HCPCS | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| 59572-0515-01 | Q2055 | Celgene Corporation | 1 | 1 |
| 59572-0515-02 | Q2055 | Celgene Corporation | 1 | 1 |
| 59572-0515-03 | Q2055 | Celgene Corporation | 1 | 1 |
Abecma: common questions
- What is the HCPCS code for Abecma?
- Abecma is billed under HCPCS Q2055. One billing unit is up to 510 million autologous anti-bcma car-positive viable t cells. CMS's crosswalk lists 3 Abecma NDCs under this code.
- How many Q2055 billing units are in a package of Abecma?
- CMS lists 1 billing units per package, depending on the NDC, where one unit is up to 510 million autologous anti-bcma car-positive viable t cells. Units to report are based on the dose given, not the package.
- Is Q2055 a CPT code?
- No. Q2055 is a HCPCS Level II code from CMS for the drug itself. Giving it, for example by injection or infusion, is usually reported with a separate CPT administration code.